Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07147023 · ClinicalTrials.gov registry record · NA

Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication

A NA study of Cancer and Advanced Cancer, sponsored by Dana-Farber Cancer Institute.

Active
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT07147023 is a NA study of Cancer and Advanced Cancer that is active but no longer recruiting, run by Dana-Farber Cancer Institute. The registered enrollment target is 60 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07147023, a NA study of Cancer and Advanced Cancer, is active but no longer recruiting, sponsored by Dana-Farber Cancer Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

The goal of this study is to test the accuracy of Large Language Model-generated serious illness communication (SIC) summaries, the feasibility of delivering the SIC summaries, and to collect perspectives on the SIC summaries from clinicians and participants with cancer. Large Language Models (LLMs) are artificial intelligence programs that can perform various natural language processing tasks.

Interventions

  • OTHER LLM SIC Summary Email

Study Locations (2)

Massachusetts

  • Brigham and Women's Hospital - Boston
  • Dana-Farber Cancer Institute - Boston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-09-15
Est. Completion 2026-10-31
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT07147023

The ClinicalTrials.gov registry entry for NCT07147023 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which LLM SIC Summary Email is the first listed.

NCT07147023 reports 2 study locations spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07147023 about?

NCT07147023 is a clinical study titled "Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication". The goal of this study is to test the accuracy of Large Language Model-generated serious illness communication (SIC) summaries, the feasibility of delivering the SIC summaries, and to collect perspectives on the SIC summaries from clinicians and participants with cancer. Large Language Models (LLMs)...

What is the current status of trial NCT07147023?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-09-15. Estimated completion is 2026-10-31.

What conditions does trial NCT07147023 study?

This clinical trial studies the following conditions: Cancer, Advanced Cancer, End of Life.

What interventions are being tested in trial NCT07147023?

The interventions under investigation include: LLM SIC Summary Email (OTHER).

Who is sponsoring clinical trial NCT07147023?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07147023 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.